The extracellular matrix of the central nervous system: Chondroitin sulphate type proteoglycans and neural repair;La matriz extracelular del sistema nervioso central: Los proteoglicanos del tipo condroitinsulfato y la reparación neural

Revista de Neurologia

Volumn 38, Issue 9, 2004, Pages 843-851

  Crespo Santiago, Dámaso ^a  

^a UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

Central nervous system; Chondroitin sulphate; Chondroitinase; Extracellular matrix; Proteoglycans; Regeneration

Indexed keywords

CHONDROITIN SULFATE; GLYCOPROTEIN; GLYCOSAMINOGLYCAN; PROTEOGLYCAN;

BRAIN DISEASE; BRAIN INJURY; CENTRAL NERVOUS SYSTEM; EXTRACELLULAR MATRIX; HOMEOSTASIS; HUMAN; NERVE REGENERATION; PROTEIN FAMILY; REVIEW;

EID: 3142731544     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3809.2003493     Document Type: Review

References (77)

1. Perides G, Rahemtulla F, Lane WS, Asher RA, Bignami A. Isolation of a large aggregating proteoglycan from human brain. J Biol Chem 1992; 267: 23883-7.
2. Asher RA, Scheibe RJ, Keiser HD, Bignami A. On the existence of a cartilage-like proteoglycan and link proteins in the central nervous system. Glia 1995; 13: 294-308.
3. Bandtlow CE, Zimmermann DR. Proteoglycans in the developing brain: new conceptual insights for old proteins. Physiol Rev 2000; 80: 1267-90.
4. Savolainen H. Isolation and separation of proteoglycans. J Chromatogr B Biomed Sci Appl 1999; 722: 255-62.
5. Sundblad G, Holojda S, Roux L, Varki A, Freeze HH. Sulfated N-linked oligosaccharides in mammalian cells. II. Identification of glycosaminoglycan- like chains attached to complex-type glycans. J Biol Chem 1988; 263: 8890-6.
6. Krusius T, Ruoslahti E. Primary structure of an extracellular matrix proteoglycan core protein deduced from cloned cDNA. Proc Natl Acad Sci USA 1986; 83: 7683-7.
7. Iozzo RV. Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem 1998; 67: 609-52.
8. Ghiselli G, Iozzo RV. Proteoglycan gene targeting in somatic cells. Methods Mol Biol 2001; 171: 239-50.
9. Murdoch AD, Iozzo RV. Prokaryotic expression of proteoglycans. Methods Mol Biol 2001; 171: 231-8.
10. Kjellen L, Lindahl U. Proteoglycans: structures and interactions. Annu Rev Biochem 1991; 60: 443-75.
11. Iozzo RV, Murdoch AD. Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function. FASEB J 1996; 10: 598-614.
12. Asher RA, Morgenstern DA, Shearer MC, Adcock KH, Pesheva P, Fawcett JW. Versican is upregulated in CNS injury and is a product of oligodendrocyte lineage cells. J Neurosci 2002; 22: 2225-36.
13. Perides G, Lane WS, Andrews D, Dahl D, Bignami A. Isolation and partial characterization of a glial hyaluronate-binding protein. J Biol Chem 1989; 264: 5981-7.
14. Zimmermann DR, Ruoslahti E. Multiple domains of the large fibroblast proteoglycan, versican. MBO J 1989; 8: 2975-81.
15. Bode-Lesniewska B, Dours-Zimmermann MT, Odermatt BF, Briner J, Heitz PU, Zimmermann DR. Distribution of the large aggregating proteoglycan versican in adult human tissues. J Histochem Cytochem 1996; 44: 303-12.
16. Ito K, Shinomura T, Zako M, Ujita M, Kimata K. Multiple forms of mouse PG-M, a large chondroitin sulfate proteoglycan generated by alternative splicing. J Biol Chem 1995; 270: 958-65.
17. Perides G, Asher RA, Lark MW, Lane WS, Robinson RA, Bignami A. Glial hyaluronate-binding protein: a product of metalloproteinase digestion of versican? Biochem J 1995; 312: 377-84.
18. Doege KJ, Sasaki M, Kimura T, Yamada Y. Complete coding sequence and deduced primary structure of the human cartilage large aggregating proteoglycan, aggrecan. Human-specific repeats, and additional alternatively spliced forms. J Biol Chem 1991; 266: 894-902.
19. Walcz E, Deak F, Erhardt P, Coulter SN, Fulop C, Horvath P, et al. Complete coding sequence, deduced primary structure, chromosomal localization, and structural analysis of murine aggrecan. Genomics 1994; 22: 364-71.
20. Margolis RU, Margolis RK. Aggrecan-versican-neurocan family proteoglycans. Methods Enzymol 1994; 245: 105-26.
21. Yamada H, Fredette B, Shitara K, Hagihara K, Miura R, Ranscht B, et al. The brain chondroitin sulfate proteoglycan brevican associates with astrocytes ensheathing cerebellar glomeruli and inhibits neurite outgrowth from granule neurons. J Neurosci 1997; 17: 7784-95.
22. Retzler C, Gohring W, Rauch U. Analysis of neurocan structures interacting with the neural cell adhesion molecule N-CAM. J Biol Chem 1996; 271: 27304-10.
23. Rauch U, Feng K, Zhou XH. Neurocan: a brain chondroitin sulfate proteoglycan. Cell Mol Life Sci 2001; 58: 1842-56.
24. Yamaguchi Y. Lecticans: organizers of the brain extracellular matrix. Cell Mol Life Sci 2000; 57: 276-89.
25. Bourdon MA, Krusius T, Campbell S, Schwartz NB, Ruoslahti E. Identification and synthesis of a recognition signal for the attachment of glycosaminoglycans to proteins. Proc Natl Acad Sci USA 1987; 84: 3194-8.
26. Krueger RC Jr, Fields TA, Hildreth J IV, Schwartz NB. Chick cartilage chondroitin sulfate proteoglycan core protein. I. Generation and characterization of peptides and specificity for glycosaminoglycan attachment. J Biol Chem 1990; 265: 12075-87.
27. Margolis RK, Rauch U, Maurel P, Margolis RU. Neurocan and phosphacan: two major nervous tissue-specific chondroitin sulfate proteoglycans. Perspect Dev Neurobiol 1996; 3: 273-90.
28. Rauch U, Clement A, Retzler C, Frohlich L, Fassler R, Gohring W, et al. Mapping of a defined neurocan binding site to distinct domains of tenascin-C. J Biol Chem 1997; 272: 26905-12.
29. Meyer-Puttlitz B, Milev P, Junker E, Zimmer I, Margolis RU, Margolis RK. Chondroitin sulfate and chondroitin/keratan sulfate proteoglycans of nervous tissue: developmental changes of neurocan and phosphacan. J Neurochem 1995; 65: 2327-37.
30. Asher RA, Morgenstern DA, Fidler PS, Adcock KH, Oohira A, Braistead JE, et al. Neurocan is upregulated in injured brain and in cytokine-treated astrocytes. J Neurosci 2000; 20: 2427-38.
31. Sandy JD, Boynton RE, Flannery CR. Analysis of the catabolism of aggrecan in cartilage explants by quantitation of peptides from the three globular domains. J Biol Chem 1991; 266: 8198-205.
32. Yamada H, Watanabe K, Shimonaka M, Yamaguchi Y. Molecular cloning of brevican, a novel brain proteoglycan of the aggrecan/versican family. J Biol Chem 1994; 269: 10119-26.
33. Little CB, Flannery CR, Hughes CE, Mort JS, Roughley PJ, Dent C, et al. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro. Biochem J 1999; 344: 61-8.
34. Watanabe K, Yamada H, Yamaguchi Y. K-glypican: a novel GPI-anchored heparan sulfate proteoglycan that is highly expressed in developing brain and kidney. J Cell Biol 1995; 130: 1207-18.
35. Filmus J, Selleck SB. Glypicans: proteoglycans with a surprise. J Clin Invest 2001; 108: 497-501.
36. Carey DJ. Syndecans: multifunctional cell-surface co-receptors. Biochem J 1997; 327: 1-16.
37. Woods A, Oh ES, Couchman JR. Syndecan proteoglycans and cell adhesion. Matrix Biol 1998; 17: 477-83.
38. Zimmermann P, David G. The syndecans, tuners of transmembrane signaling. FASEB J 1999; 13 (Suppl): S91-100.
39. Rapraeger AC, Ott VL. Molecular interactions of the syndecan core proteins. Curr Opin Cell Biol 1998; 10: 620-8.
40. Rapraeger AC. Molecular interactions of syndecans during development. Semin Cell Dev Biol 2001; 12: 107-16.
41. Maurel P, Rauch U, Flad M, Margolis RK, Margolis RU. Phosphacan, a chondroitin sulfate proteoglycan of brain that interacts with neurons and neural cell-adhesion molecules, is an extracellular variant of a receptor-type protein tyrosine phosphatase. Proc Natl Acad Sci USA 1994; 91: 2512-6.
42. Maeda N, Hamanaka H, Oohira A, Noda M. Purification, characterization and developmental expression of a brain-specific chondroitin sulfate proteoglycan, 6B4 proteoglycan/phosphacan, Neuroscience 1995; 67: 23-35.
43. Canoll PD, Petanceska S, Schlessinger J, Musacchio JM. Three forms of RPTP-beta are differentially expressed during gliogenesis in the developing rat brain and during glial cell differentiation in culture. J Neurosci Res 1996; 44: 199-215.
44. Oohira A, Matsui F, Tokita Y, Yamauchi S, Aono S, Molecular interactions of neural chondroitin sulfate proteoglycans in the brain development. Arch Biochem Biophys 2000; 374: 24-34.
45. Allendoerfer KL, Durairaj A, Matthews GA, Patterson PH. Morphological domains of Lewis-X/FORSE-1 immunolabeling in the embryonic neural tube are due to developmental regulation of cell surface carbohydrate expression. Dev Biol 1999; 211: 208-19.
46. Zhang Y, Sinay P. Synthesis and characterization of a sulfated pentasaccharide containing the Lewis-X motif. Carbohydr Res 2003; 338: 1793-5.
47. Garwood J, Heck N, Reichardt F, Faissner A. Phosphacan short isoform, a novel non-proteoglycan variant of phosphacan/receptor protein tyrosine phosphatase-beta, interacts with neuronal receptors and promotes neurite outgrowth. J Biol Chem 2003; 278: 24164-73.
48. Miyata S, Shinga I, Taguchi K, Nakashima T, Kiyohara T, Oohira A. Chondroitin sulfate proteoglycan phosphacan/RPTPbeta in the hypothalamic magnocellular nuclei. Brain Res 2002; 949: 112-21.
49. Nishiyama A. NG2 cells in the brain: a novel glial cell population. Hum Cell 2001; 14: 77-82.
50. Nishiyama A, Chang A, Trapp BD. NG2+ glial cells: a novel glial cell population in the adult brain. J Neuropathol Exp Neurol 1999; 58: 1113-24.
51. Schwartz S, Rieder H, Schlager B, Burmeister T, Fischer L, Thiel E. Expression of the human homologue of rat NG2 in adult acute lymphoblastic leukemia: close association with MLL rearrangement and a CD10(-)/CD24(-)/ CD65s(+)/CD15(+) B-cell phenotype. Leukemia 2003; 17: 1589-95.
52. Salinero O, Moreno-Flores MT, Wandosell F. Increasing neurite outgrowth capacity of beta-amyloid precursor protein proteoglycan in Alzheimer's disease. J Neurosci Res 2000; 60: 87-97.
53. Beyreuther K, Multhaup G, Monning U, Sandbrink R, Beher D, Hesse L, et al. Regulation of APP expression, biogenesis and metabolism by extracellular matrix and cytokines. Ann NY Acad Sci 1996; 777: 74-6.
54. Sandbrink R, Monning U, Masters CL, Beyreuther K. Expression of the APP gene family in brain cells, brain development and aging. Gerontology 1997; 43: 119-31.
55. Morgenstern R, Asher RA, Fawcett JW. Chondroitin sulphate proteoglycans in the CNS injury response. Prog Brain Res 2002; 137: 313-32.
56. Oakley RA, Tosney KW. Peanut agglutinin and chondroitin-6-sulfate are molecular markers for tissues that act as barrier to axon advance in the avian embryo. Dev Biol 1991; 147: 187-206.
57. Pindzola RR, Doller C, Silver J. Putative inhibitory extracellular matrix molecules at the dorsal root entry zone of the spinal cord during development and after root and sciatic nerve lesions. Dev Biol. 1993; 156: 34-8.
58. Hoffman-Kim D, Lander AD, Jhaveri S. Patterns of chondroitin sulfate immunoreactivity in the developing tectum reflect regional differences in glycosaminoglycans biosynthesis. J Neurosci 1998; 18: 5881-90.
59. Brittis PA, Canning DR, Silver J. Chondroitin sulfate as a regulator of neuronal patterning in the retina. Science 1992; 255: 733-6.
60. Lips K, Stichel CC, Muller HW. Restricted appearance of tenascin and chondroitin sulphate proteoglycans after transection and sprouting of adult rat postcommissural fornix. J Neurocytol 1995; 24: 449-64.
61. Gates MA, Fillmore H, Steindler DA. Chondroitin sulfate proteoglican and tenascin in the wounded adult mouse neostriatum in vitro: dopamine neuron attachment and process outgrowth. J Neurosci 1996; 16: 8005-18.
62. Fitch MT, Silver J. Activated macrophages and the blood-brain barrier: inflammation after CNS injury leads to increases in putative inhibitory molecules. Exp Neurol 1997; 148: 587-03.
63. Bovolenta P, Wandosell F, Nieto-Sampedro M. Characterization of a neurite outgrowth inhibitor expressed after CNS injury. Eur J Neurosci 1993; 5: 454-65.
64. Bovolenta P, Fernaud-Espinosa I, Méndez-Otero R, Nieto-Sampedro M. Neurite outgrowth inhibitor of gliotic brain tissue. Mode of action and cellular localization, studies with specific monoclonal antibodies. Eur J Neurosci 1997; 9: 977-89.
65. Davies SJ, Fitch MT, Memberg SP, Raisman G, Silver J. Regeneration of adult axons in white matter tracts of the central nervous system. Nature 1997; 390: 680-3.
66. Davies SJ, Goucher DR, Doller C, Silver J. Robust regeneration of adult sensory axons in degenerating white matter of the adult rat spinal cord. J Neurosci 1999; 19: 5810-22.
67. Chen ZJ, Ughrin Y, Levine JM. Inhibition of axon growth by oligodendrocyte precursor cells. Mol Cell Neurosci 2002; 20: 125-39.
68. Oleszewski M, Gutwein P, Von der Lieth W, Rauch U, Altevogt P. Characterization of the L1-neurocan-binding site. Implications for L1-L1 homophilic binding. J Biol Chem 2000; 275: 34478-85.
69. Katoh-Semba R, Matsuda M, Kato K, Oohira A. Chondroitin sulphate proteoglycans in the rat brain: candidates for axon barriers of sensory neurons and the possible modification by laminin of their actions. Eur J Neurosci 1995; 7: 613-21.
70. Katoh-Semba R, Matsuda M, Watanabe E, Maeda N, Oohira A. Two types of brain chondroitin sulfate proteoglycan: their distribution and possible functions in the rat embryo. Neurosci Res 1998; 31: 273-82.
71. Asher RA, Morgenstern DA, Fidler PS, Adcock KH, Oohira A, Braistead JE, et al. Neurocan is upregulated in injured brain and in cytokine-treated astrocytes. J Neurosci 2000; 20: 2427-38.
72. McKeon RJ, Jurynec MJ, Buck CR. The chondroitin sulfate proteoglycans neurocan and phosphacan are expressed by reactive astrocytes in the chronic CNS glial scar. J Neurosci 1999; 19: 10778-88.
73. Haas CA, Rauch U, Thon N, Merten T, Deller T. Entorhinal cortex lesion in adult rats induces the expression of the neuronal chondroitin sulfate proteoglycan neurocan in reactive astrocytes. J Neurosci 1999; 19: 9953-63.
74. Rabchevsky AG, Degos JD, Dreyfus PA. Peripheral injections of Freund's adjuvant in mice provoke leakage of serum proteins through the blood-brain barrier without inducing reactive gliosis. Brain Res 1999; 832: 84-96.
75. Rabchevsky AG, Weinitz JM, Coulpier M, Fages C, Tinel M, Junier MP. A role for transforming growth factor alpha as an inducer of astrogliosis. J Neurosci 1998; 18: 10541-52.
76. Kresse H, Schonherr E. Proteoglycans of the extracellular matrix and growth control. Cell Physiol 2001; 189: 266-74.
77. Rhodes KE, Moon LD, Fawcett JW. Inhibiting cell proliferation during formation of the glial scar: effects on axon regeneration in the CNS. Neuroscience 2003; 120: 41-56.